IRIS
OLIVERO, GUENDALINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.300
Totale 7.300
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 7.300
Totale 7.300
Salva come PNG Salva come JPEG
Città #
Genova 4.284
Rapallo 1.289
Genoa 1.116
Vado Ligure 594
Bordighera 17
Totale 7.300
Salva come PNG Salva come JPEG
Nome #
Dangerous liaisons between beta-amyloid and cholinergic neurotransmission 147
Chronic nicotine exposure selectively activates a carrier-mediated release of endogenous glutamate and aspartate from rat hippocampal synaptosomes 146
In vitro exposure to nicotine induces endocytosis of presynaptic AMPA receptors modulating dopamine release in rat Nucleus Accumbens nerve terminals 145
Environmental Training And Synaptic Functions In Young And Old Brain: A Presynaptic Perspective 145
Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in rat hippocampus 143
Presynaptic mGlu1 Receptors Control GABAB Receptors in an Antagonist-Like Manner in Mouse Cortical GABAergic and Glutamatergic Nerve Endings 142
Prophylactic versus therapeutic fingolimod: Restoration of presynaptic defects in mice suffering from experimental autoimmune encephalomyelitis 132
Environmental training is beneficial to clinical symptoms and cortical presynaptic defects in mice suffering from experimental autoimmune encephalomyelitis 129
Beta Amyloid Differently Modulate Nicotinic and Muscarinic Receptor Subtypes which Stimulate in vitro and in vivo the Release of Glycine in the Rat Hippocampus 129
Aß influences nicotinic-stimulated release of both excitatory and inhibitory neurotransmitters in rat hippocampus 128
CXCR4 and NMDA Receptors Are Functionally Coupled in Rat Hippocampal Noradrenergic and Glutamatergic Nerve Endings 125
Effects of the neoclerodane Hardwickiic acid on the presynaptic opioid receptors which modulate noradrenaline and dopamine release in mouse central nervous system 121
Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer's disease and other tauopathies 119
Dual Effect of Beta-Amyloid on α7 and α4β2 Nicotinic Receptors Controlling the Release of Glutamate, Aspartate and GABA in Rat Hippocampus 116
Beta Amyloid and cholinergic system: old actors for new different roles 113
Immuno-Pharmacological Characterization of Presynaptic GluN3A-Containing NMDA Autoreceptors: Relevance to Anti-NMDA Receptor Autoimmune Diseases 112
Immuno-pharmacological characterization of group II metabotropic glutamate receptors controlling glutamate exocytosis in mouse cortex and spinal cord 110
< i> In vitro exposure to nicotine modulate the function of presynaptic NMDA receptors present on dopaminergic terminals in rat Nucleus Accumbens 108
Prolonged nicotine exposure down-regulates presynaptic \NMDA\ receptors in dopaminergic terminals of the rat nucleus accumbens 106
5-HT2A-mGlu2/3 receptor complex in rat spinal cord glutamatergic nerve endings: A 5-HT2Ato mGlu2/3 signalling to amplify presynaptic mechanism of auto-control of glutamate exocytosis 99
The reduction in glutamate release is predictive of cognitive and emotional alterations that are corrected by the positive modulator of AMPA receptors S 47445 in perinatal stressed rats 99
Presynaptic modulation of cholinergic neurotransmission 90
null 89
Isolation of hydroxyoctaprenyl-1’,4’-hydroquinone, a new octaprenylhydroquinone from the marine sponge Sarcotragus spinosulus and evaluation of its pharmacological activity on acetylcholine and glutamate release in the rat Central Nervous System. 89
β-amyloid differently modulates the function of nAChRs which stimulate the release of glutamate, aspartate, glycine and GABA in rat hippocampus 88
Prolonged activation of CXCR4 hampers the release-regulating activity of presynaptic NMDA receptors in rat hippocampal synaptosomes 88
Presynaptic, release-regulating mGlu2-preferring and mGlu3-preferring autoreceptors in CNS: pharmacological profiles and functional roles in demyelinating disease 87
β-amyloid impairs the nicotinic-stimulated neurotransmitter release in rat hippocampus in absence of neurotoxicity 85
Pre-exposure to nicotine induces endocytosis of presynaptic AMPA receptors modulating dopamine release in rat Nucleus Accumbens synaptosomes 85
In vitro pre-exposure to nicotine: modulation of presynaptic NMDA receptors present on dopaminergic terminals in rat Nucleus Accumbens. 80
In vitro exposure to nicotine modulates the function of presynaptic NMDA receptors present on dopaminergic terminals in rat Nucleus Accumbens 78
βamyloid differently regulates the function of nAChRs which stimulate the release of glutamate, aspartate, glycine and GABA in rat hippocampus 77
The Functional cross-talk between nicotinic and glutamatergic receptors on dopaminergic nerve terminals in the rat nucleus accumbens 76
Autoimmune synaptopathies: roles of antibodies targeting neurotransmitter receptors and complement 75
Environmental training on clinical symptoms and synaptic defects in aged mice: a pre-clinical study to support the rehabilitative approach in clinic 75
STUDIO DEGLI EFFETTI DI MOLECOLE ESTRATTE DA SALVIE COME MODULATORIDELLA NEUROTRASMISSIONE CENTRALE 73
Salviae neoclerodane derivatives differently affect catecholamine release in mammal brains: comparison with Salvinorin 72
Nicotinic a7 and non-a7 receptors modulate endogenous aminoacids release from rat hippocampal synaptosomes 72
Different Effects of Beta Amyloid on α7 and α4β2 Nicotinic Receptors Controlling the Release of Aminoacids in Rat Hippocampal nerve endings 70
5HT2A- mGlu2/3 receptor-receptor interaction in the spinal cord of adult rats: new pharmacological approaches to treat hyperglutamatergicity 70
Linking NMDA Receptor Synaptic Retention to Synaptic Plasticity and Cognition 69
Effects of soluble beta-amyloid on the release of neurotransmitters from rat brain synaptosomes 67
Neuroinflammation in Aged Brain: Impact of the Oral Administration of Ellagic Acid Microdispersion 64
Acute Low Dose of Trazodone Recovers Glutamate Release Efficiency and mGlu2/3 Autoreceptor Impairments in the Spinal Cord of Rats Suffering From Chronic Sciatic Ligation 64
CCL5 as a mediator for neuron-glia communication to modulate nociceptive signal transmission 62
The 3Rs: reduction and refinement through a multivariate statistical analysis approach in a behavioural study to unveil anxiolytic effects of natural extracts of Tilia Tomentosa. 62
Receptor-receptors functional cross-talk: new evidences on nicotine-NMDA receptor interaction 61
Gender and age dependency of the effects of Bud extracts from Tilia tomentosa Moench in central nervous system 61
Release regulating mGlu2-preferring and mGlu3 preferring autoreceptors in CNS 60
Functional cross-talk between NMDA and CXCR4 receptors in rat hippocampal nerve endings 59
The 3Rs: Reduction and refinement through a multivariate statistical analysis approach in a behavioural study to unveil anxiolytic effects of natural extracts of Tilia tomentosa 59
Pharmacological profiles and functional roles of presynaptic, release regulating mGlu2-preferring and mGlu3-preferring autoreceptors and their role in demyelinating disease. 58
Nicotinic alpha7 receptor activation selectively potentiates the function of NMDA receptors in glutamatergic terminals of the nucleus accumbens 56
Complement modulatory effects on hippocampal glutamatergic neurotransmission 56
mGlu1 receptor and GABAB receptor heterodimerization in cortical nerve terminals. 56
Pharmacological profiles and functional roles of presynaptic, release regulating mGlu2/3 autoreceptors in the spinal cord. 54
Presynaptic release-regulating metabotropic glutamate receptors: An update 51
Immunopharmacological characterization of presynaptic release-regulating AMPA autoreceptors in the cortex of mice 50
Effects of bud extracts from Tilia tomentosa Moench in central nervous system of mice: gender and age- dependency 48
Complement controls glutamate release in central nervous system. 48
Immuno-pharmacological characterization of the NMDA autoreceptors regulating glutamate release in the hippocampus: relevance to anti-NMDA receptor autoimmune diseases. 48
The promnesic effects of Tilia tomentosa bud extracts on old male mice 48
5-HT2A-mGlu2/3 receptors metamodulation in the spinal cord: a novel approach for the cure of neuropathic pain 48
New advances in the knowledge of the 5HT2A / mGlu2/3 receptor-receptor functional cross talk in mammal central nervous system 47
Video tracking analysis of behavioral scores: The Finnover experience 46
Sphingosine-1-phosphate receptors control glutamate release in mice cortical nerve endings and glial particles 45
Healthy Properties of a New Formulation of Pomegranate-Peel Extract in Mice Suffering from Experimental Autoimmune Encephalomyelitis 45
Complement modulatory effects on glutamatergic neurotransmission in central nervous system 43
Antibodies Against the NH2-Terminus of the GluA Subunits Affect the AMPA-Evoked Releasing Activity: The Role of Complement 43
Immuno-pharmacological characterization of group II metabotropic glutamate receptors controlling glutamate release in mouse cortex and spinal cord 42
Environmental training ameliorates the course of demyelinating disease in mice: a glutamatergic hypothesis 41
Release-regulating sphingosine-1-phosphate receptors in nerve endings and glial particles of mice central nervous system. 41
A higher level of integration in the neuronal network of mouse cortex: the role of interaction between mGluR 1 heteroreceptors and GABAb autorecepetors 41
Presynaptic release-regulating alpha2 autoreceptors: Potential molecular target for ellagic acid nutraceutical properties 41
Impact of the oral administration of an ellagic acid micro-dispersion on neuroinflammation in brain aging. 41
GLI EFFETTI ANSIOLITICI E PROMNESICI DEGLI ESTRATTI DI TILIA TOMENTOSA: UNO STUDIO PRECLINICO 41
Enriched environment in multiple sclerosis-related synaptopathy: the positive role in mice suffering from experimental autoimmune enchephalomyelitis 40
Specific neuromodulatory actions of beta-amyloid: novel mechanisms. 40
Exposure to environmental training ameliorates the course of demyelinating disease in mice: a glutamatergic hypothesis. 40
Antibodies for the pharmacological characterization of presynaptic, release-regulating mGlu2-preferring and mGlu3- preferring autoreceptors in mouse CNS 40
Healthy properties of a new formulation of pomegranate peel extract in an animal model of multiple sclerosis 40
Functional interaction between presynaptic receptors on dopaminergic and noradrenergic nerve terminals of the rat central nervous system 39
Inhibitory effects of beta-amyloid 1-40 on the nicotine-evoked neurotransmitters release in the rat central nervous system. 38
Functional interaction between presynaptic nicotinic and NMDA receptors on dopaminergic and noradrenergic nerve terminals of the rat central nervous system 38
Nicotinic α7 receptor activation induces NMDA receptors trafficking in glutamatergic terminals of the nucleus accumbens 38
Nicotine pre-exposure selectively modulates the function of NMDA receptors present on glutamatergic terminals. 38
Receptor-receptors functional cross-talk: a focus on nicotine NMDA receptor interaction. 37
Prolonged "in vitro" exposure to nicotine modulate the function of presynaptic GABA B autoreceptors present on gabaergic nerve endings in rat hippocampus 36
Enriched environment in multiple sclerosis-related pathology: the positive role in mice suffering from experimental autoimmune encephalomyelitis. 36
Neuroinflammation in aged brain: impact of the oral administration of ellagic acid microdispersion 36
Serotonergic metamodulation of mGlu2/3 autoreceptors in the spinal cord as a novel approach for the cure of neuropathic pain 36
Complement tunes glutamate release and supports synaptic impairments in an animal model of multiple sclerosis 35
null 35
Complement and glutamatergic neurotransmission: a presynaptic point of view 35
Roles of antibodies targeting neurotransmitter receptors and complement in the modulation of glutamatergic hippocampal neurotransmission: relevance to autoimmune synaptopathies. 34
In vitro exposure to nicotinic agonists modulates the function of NMDA receptors present on glutamatergic and GABAergic nerve endings in rat nucleus Accumbens. 34
Functional interaction between presynaptic receptors on dopaminergic and noradrenergic nerve terminals of the rat central nervous system. 34
Intraneuronal and extraneuronal inhibitory effects of beta-amyloid: focus on nicotinic and muscarinic receptors 34
Effects of β-amyloid fragments on nicotinic modulation of dopamine release from rat nucleus accumbens nerve endings 33
Somatostatin, a presynaptic modulator of glutamatergic signal in the central nervous system 33
Totale 6.878
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.321
article - articoli 12.175
book - libri 0
conference - conferenze 16.925
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 221
Totale 58.642
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.340 0 0 0 0 112 156 210 94 116 351 259 42
2020/2021550 26 51 27 17 26 54 84 58 69 44 45 49
2021/20221.207 40 79 63 70 90 80 45 297 68 125 61 189
2022/20231.555 151 156 27 137 204 243 42 93 248 11 226 17
2023/2024852 44 98 12 132 88 138 65 26 31 33 75 110
2024/2025647 86 167 63 166 165 0 0 0 0 0 0 0
Totale 7.587